Edition:
United Kingdom

SAGE Therapeutics Inc (SAGE.OQ)

SAGE.OQ on NASDAQ Stock Exchange Global Market

166.71USD
18 Jan 2018
Change (% chg)

$-1.77 (-1.05%)
Prev Close
$168.48
Open
$167.12
Day's High
$172.65
Day's Low
$166.13
Volume
134,965
Avg. Vol
308,954
52-wk High
$180.50
52-wk Low
$44.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -1.879
Mar '17 0.00 -1.523
FY 2016 Dec '16 0.00 -1.498
Sep '16 0.00 -1.146
Jun '16 0.00 -1.084
Mar '16 0.00 -0.965
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 7 0.00 0.00 0.00 --
Quarter Ending Jun-18 7 0.00 0.00 0.00 --
Year Ending Dec-18 14 9.98 57.40 0.00 53.58
Earnings (per share)
Quarter Ending Mar-18 7 -2.00 -1.79 -2.26 --
Quarter Ending Jun-18 7 -2.19 -1.79 -2.74 --
Year Ending Dec-18 13 -8.29 -6.59 -10.97 -4.19
LT Growth Rate (%) 1 -15.20 -15.20 -15.20 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.75 32.90
P/E High - Last 5 Yrs. -- 302.25 46.03
P/E Low - Last 5 Yrs. -- 94.23 24.39
Beta -- 0.88 0.89
Price to Sales (TTM) -- 94.46 5.41
Price to Book (MRQ) 9.22 13.37 5.38
Price to Tangible Book (MRQ) 9.22 13.65 6.89
Price to Cash Flow (TTM) -- 72.91 23.43
% Owned Institutions -- 11.52 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.51
Dividend 5 Year Growth Rate -- 1.72 5.23
Payout Ratio(TTM) -- 16.23 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 401.35 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 70.94 5.44
Sales - 5 Yr. Growth Rate -- 33.11 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -73.38 29.52 19.33
EPS (TTM) vs TTM 1 Yr. Ago -55.99 -- --
EPS - 5 Yr. Growth Rate -- 40.23 10.77
Capital Spending - 5 Yr. Growth Rate -- 40.36 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.18
Current Ratio (MRQ) 9.02 5.22 2.97
LT Debt to Equity (MRQ) 0.00 21.07 12.10
Total Debt to Equity (MRQ) 0.00 22.62 16.38
Interest Coverage (TTM) -- -102.11 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.23 54.86
Gross Margin - 5 Yr. Avg. -- 52.57 52.45
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -239.65 15.33
Operating Margin (TTM) -- -519.48 7.74
Operating Margin - 5 Yr. Avg. -- -256.84 10.79
Pre-Tax Margin (TTM) -- -495.13 8.53
Pre-Tax Margin - 5 Yr. Avg. -- -256.77 11.19
Net Profit Margin (TTM) -- -496.63 4.84
Net Profit Margin - 5 Yr. Avg. -- -259.99 7.50
Effective Tax Rate (TTM) -- 23.31 23.05
Effective Tax Rate - 5 Yr. Avg. -- 18.78 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,331,032 855,738,258
Net Income/Employee (TTM) -1,634,645 3,081,067 100,666,768
Receivable Turnover (TTM) -- 20.25 5.76
Inventory Turnover (TTM) -- 2.31 3.34
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -77.56 0.10 10.97
Return on Assets - 5 Yr. Avg. -- 0.51 12.39
Return on Investment (TTM) -85.13 3.21 14.40
Return on Investment - 5 Yr. Avg. -- 3.64 16.20
Return on Equity (TTM) -85.28 4.54 16.09
Return on Equity - 5 Yr. Avg. -- 8.99 17.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -39.54 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for SAGE Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 264
Total Shares Held: 41,912,148
3 Mo. Net Change: 25,071
# New Positions: 4
# Closed Positions: 4
# Increased Positions: 14
# Reduced Positions: 12
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.